WE ARE FOR YOU
FOR PATIENTS
With current medicine development patients and doctors now have hope for discovering new medicine for incurable and chronic diseases. However, prior to a release of a new drug on the market, in hospitals and pharmacies it has to go through multi stage process of clinical trials. It regards effectiveness, safety, and occurrence of side effects.
Clinical trial participants have access to the latest treatments today.
A PATIENT, WHO PARTICIPATES IN CLINICAL TRIALS, HELPS HIMSELF AND OTHER PEOPLE WITH THE SAME DISEASE, THROUGH THIS HE AFFECTS MEDICINAL DEVELOPMENT AND THE IMPROVEMENT OF HEALTH CARE QUALITY
FOR CRO COMPANY / SPONSOR
The EuroMedis Clinical Trial Center was established because we believe that by participating in the development of innovative ideas and medical technologies we improve the quality of life of our patients.
That is why in our facility we have created conditions for conducting and developing clinical trials that meet the highest standards.
Our main goal is to use our own many years of experience in expanding the field of conducted clinical trials, both in cooperation with sponsors and the CRO, as well as other clinical research centers wanting to increase the effectiveness of their work.
BET OUR EXPERIENCE AND EFFCIENCY!
FOR REFERRALS
Involvement in clinical trials means access to the latest therapeutic methods and diagnostics that are not available in standard medical care.
We invite all doctors who want to broaden their knowledge about clinical trials and possibilities of modern treatment and above all want to participate in creating medicine of the future.
YOUR COMMITMENT IS NECESSARY!
WHAT’S NEW IN THE CLINICAL TRIALS CENTER?
LATEST HEALTH ARTICLES
O otępieniach
Sorry, this entry is only available in Polish. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch [...]
CURRENT INFORMATIONS
Bezpłatne konsultacje lekarskie dla osób z polineuropatią cukrzycową lub neuropatią półpaśćcową
Sorry, this entry is only available in Polish. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch [...]